The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (hereafter termed "Fragile X Centers").
In recognition of the rapidly evolving landscape of FMR1-associated research, NIH recently published a new Strategic Plan for Research on FMR1-Associated Conditions. This Strategic Plan, which was developed in collaboration with many members of the Fragile X community, articulates NIH’s current research priorities, which are directed toward an overarching vision of accelerating the development of effective interventions to prevent or treat FMR1-associated conditions. Successful Fragile X Centers will be composed of multidisciplinary teams of basic, translational and clinical investigators collaborating to address complex, difficult-to-solve problems within specific research priorities identified in the Strategic Plan.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): April 3, 2020
RFA-HD-20-003 Expiration Date April 4, 2020
Center PD(s)/PI(s) cannot serve as the Lead of a core or research project on another active Fragile X Center.
Applicants may request up to $1.3 million in direct costs per year (excluding subaward F&A costs).
The scope of the proposed project should determine the project period. The maximum project period is 5 years.